Deutsche Bank Aktiengesellschaft Raises UnitedHealth Group (NYSE:UNH) Price Target to $625.00

UnitedHealth Group (NYSE:UNH) had its target price boosted by investment analysts at Deutsche Bank Aktiengesellschaft from $595.00 to $625.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the healthcare conglomerate’s stock. Deutsche Bank Aktiengesellschaft’s price target would suggest a potential upside of 2.71% from the stock’s previous close.

Several other equities research analysts have also commented on UNH. Barclays boosted their price objective on shares of UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 27th. Stephens decreased their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Bank of America decreased their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. TD Cowen increased their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Finally, Royal Bank of Canada reduced their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $621.58.

UnitedHealth Group Trading Down 0.3 %

UnitedHealth Group stock opened at $608.52 on Tuesday. The firm’s 50-day moving average is $585.43 and its 200-day moving average is $556.65. The company has a market cap of $560.01 billion, a P/E ratio of 39.64, a PEG ratio of 1.79 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. UnitedHealth Group has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $6.56 EPS. On average, equities analysts expect that UnitedHealth Group will post 27.6 earnings per share for the current year.

Institutional Trading of UnitedHealth Group

Institutional investors have recently added to or reduced their stakes in the business. Inspire Trust Co. N.A. raised its holdings in UnitedHealth Group by 2.8% during the third quarter. Inspire Trust Co. N.A. now owns 9,102 shares of the healthcare conglomerate’s stock valued at $5,322,000 after acquiring an additional 251 shares during the period. Beaird Harris Wealth Management LLC raised its stake in UnitedHealth Group by 124.2% in the 3rd quarter. Beaird Harris Wealth Management LLC now owns 287 shares of the healthcare conglomerate’s stock valued at $168,000 after purchasing an additional 159 shares during the last quarter. Franklin Resources Inc. lifted its holdings in UnitedHealth Group by 2.5% during the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after buying an additional 193,800 shares in the last quarter. Peapack Gladstone Financial Corp lifted its stake in UnitedHealth Group by 1.7% in the 3rd quarter. Peapack Gladstone Financial Corp now owns 70,718 shares of the healthcare conglomerate’s stock valued at $41,348,000 after buying an additional 1,200 shares in the last quarter. Finally, Tidal Investments LLC grew its stake in shares of UnitedHealth Group by 12.7% in the third quarter. Tidal Investments LLC now owns 35,458 shares of the healthcare conglomerate’s stock valued at $20,732,000 after buying an additional 3,993 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.